高级检索

    NCPAP和NIV-NAVA在新生儿RDS有创机械通气拔管后 无创呼吸支持中的应用比较

    Comparison of NCPAP and NIV-NAVA in non-invasive respiratory support after extubation of neonatal RDS invasive mechanical ventilation

    • 摘要: 目的 比较经鼻持续气道正压通气 (nasal continuous positive airway pressure,NCPAP) 和无创神经调节通气辅助 (noninvasive neurally adjusted ventilatory assistance,NIV-NAVA) 对早产儿拔管后稳定性的影响。方法 选取2019年1月—2020年6月在沧州市妇幼保健院治疗的新生儿呼吸窘迫综合征(respiratory distress syndrome,RDS)患儿72例为研究对象。按照随机数字表法将患儿分为2组(NCPAP组和NIV-NAVA组)各36例。分别记录患儿撤机失败率、人机不同步发生情况、人机不同步指数、总用氧时间、无创时间以及无创后吸氧时间,并检测治疗前后相关血气分析指标,如pH值、二氧化碳分压(PaCO2)、氧分压(PaO2),氧合指数(oxygenation index,OI)以及不同分组的并发症发生情况。结果 NCPAP组和NIV-NAVA组在撤机失败率、人机不同步发生情况、人机不同步指数、总用氧时长相对比,差异无统计学意义(P>0.05);NIV-NAVA组患者的无创呼吸支持时间是2(1,3)d,显著短于NCPAP组的5(3,6)d,差异具有统计学意义(P<0.05);治疗前后,2组的pH值、PaCO2、PaO2水平比较差异均无统计学意义(P>0.05);NIV-NAVA组患儿在接受治疗后12 h、24 h的OI分别为238.52±32.94和258.18±40.75,明显高于NCPAP组(P<0.05);NIV-NAVA组和NCPAP组并发症发生率比较,差异无统计学意义(P>0.05)。结论 与NCPAP相比,早产儿在气管插管拔管后应用NIV-NAVA可缩短无创呼吸支持时间,且应用NIV-NAVA能减少人机不同步的发生,值得临床使用。

       

      Abstract: Objective To compare the effects of nasal continuous positive airway pressure (NCPAP) and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) on the stability of premature infants after extubation. Methods A total of 72 neonates who suffered from respiratory distress syndrome (RDS) and treated in Cangzhou Maternal and Child Healthcare Hospital from January 2019 to June 2020 were enrolled. According to the random table method, they were divided into two groups (n=36): a NCPAP group and a NIV-NAVA group. Their failure rate of weaning, the occurrence of asynchrony between man and machine, the index of man-machine asynchrony, total oxygen time, non-invasive time and non-invasive oxygen time after treatment were recorded. Meanwhile, blood gas analysis was performed before and after treatment to record pH value, partial pressure of carbon dioxide (PaCO2), partial pressure of oxygen (PaO2), and oxygenation index (OI). Furthermore, the occurrence of complications in different groups was recorded. Results There was no statistical difference in the failure rate of weaning, the occurrence of asynchrony between man and machine, the index of man-machine asynchrony, total oxygen time between the NCPAP group and NIV-NAVA group (P>0.05). The NIV-NAVA group require 2(1,3) days for noninvasive respiratory support, which was significantly shorter than 5 (3, 6) days in the NCPAP group (P<0.05). No statistical difference was found in pH, PaCO2, and PaO2 in the two groups before and after treatment (P>0.05). For patients in the NIV-NAVA group, the OI values were 238.52±32.94 and 258.18±40.75 for treatment of 12 h and 24 h, respectively, which were significantly higher than those in the NCPAP group (P<0.05). There was no statistical difference as to the incidence of complications between the NIV-NAVA group and the NCPAP group (P>0.05). Conclusions Compared with NCPAP, the application of NIV-NAVA after tracheal intubation and extubation in premature infants can shorten non-invasive respiratory support time, and reduce the occurrence of man-machine asynchrony, which is worthy of clinical use.

       

    /

    返回文章
    返回